Equities analysts predict that Aurora Cannabis Inc (NYSE:ACB) will announce earnings of ($0.02) per share for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Aurora Cannabis’ earnings, with the highest EPS estimate coming in at $0.00 and the lowest estimate coming in at ($0.04). Aurora Cannabis posted earnings per share of $0.13 in the same quarter last year, which indicates a negative year over year growth rate of 115.4%. The company is scheduled to announce its next quarterly earnings results on Tuesday, September 24th.
On average, analysts expect that Aurora Cannabis will report full-year earnings of ($0.18) per share for the current fiscal year, with EPS estimates ranging from ($0.21) to ($0.16). For the next fiscal year, analysts forecast that the company will post earnings of ($0.02) per share, with EPS estimates ranging from ($0.10) to $0.04. Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that cover Aurora Cannabis.
ACB has been the topic of several analyst reports. Desjardins initiated coverage on shares of Aurora Cannabis in a report on Thursday, April 25th. They issued a “buy” rating and a $9.07 price objective on the stock. Seaport Global Securities initiated coverage on shares of Aurora Cannabis in a report on Thursday, February 21st. They issued a “neutral” rating on the stock. GMP Securities restated a “hold” rating and issued a $9.50 price objective on shares of Aurora Cannabis in a report on Tuesday, February 12th. Cowen initiated coverage on shares of Aurora Cannabis in a report on Tuesday, March 5th. They issued an “outperform” rating on the stock. Finally, TheStreet lowered shares of Aurora Cannabis from a “c” rating to a “d+” rating in a report on Monday, February 25th. One research analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $9.86.
Shares of ACB traded down $0.21 during mid-day trading on Wednesday, hitting $8.68. 19,179,293 shares of the company traded hands, compared to its average volume of 16,737,862. Aurora Cannabis has a one year low of $4.05 and a one year high of $12.52. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.37 and a quick ratio of 2.50. The stock has a market capitalization of $9.02 billion, a P/E ratio of 72.33 and a beta of 2.82.
Aurora Cannabis Company Profile
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Featured Article: How to calculate the annual rate of depreciation
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.